TY - JOUR
T1 - Hospital Diabetes Meeting 2020
AU - Umpierrez, Guillermo
AU - Rushakoff, Robert
AU - Seley, Jane Jeffrie
AU - Zhang, Jennifer Y.
AU - Shang, Trisha
AU - Han, Julia
AU - Spanakis, Elias K.
AU - Alexanian, Sara
AU - Drincic, Andjela
AU - Kulasa, Kristen
AU - Mendez, Carlos E.
AU - Tanton, Damon
AU - Wallia, Amisha
AU - Zilbermint, Mihail
AU - Klonoff, David C.
N1 - Funding Information:
The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Guillermo Umpierrez is the editor-in-chief for BMJ Open Diabetes Research & Care. He has received research funding from Sanofi, Novo Nordisk, Dexcom, and AstraZeneca. Robert Rushakoff, Jane Jeffrie Seley, Jennifer Zhang, Trisha Shang, Julia Han, Sara Alexanian, Andjela Drincic, and Kristen Kulasa have nothing to disclose. Carlos E. Mendez serves on the Medical Advisory Board for Monarch Medical Technologies (EndoTool). Elias Spanakis was partially supported by the VA MERIT award (#1I01CX001825) from the U.S. Department of Veterans Affairs Clinical Sciences Research and Development Service. EKS has received unrestricted research support from Dexcom (to Baltimore VA Medical Center and to University of Maryland) for the conduction of clinical trials. Damon Tanton has been an advisor or consultant for Novo Nordisk, Janssen, BI-Lilly, Merck, and Xeris. He serves as a speaker or as a member of a speakers’ bureau for GLYTEC. Amisha Wallia has received research funding from Novo Nordisk and research support from Eli Lilly and the UnitedHealth Group. Mihail Zilbermint is a consultant for Guidepoint, G.L.G., and has invested in Sacramento Healthcare Investors, LP. David C. Klonoff is a consultant for Dexcom, Eoflow, Fractyl, Lifecare, Novo, Roche, and Thirdwayv.
Publisher Copyright:
© 2020 Diabetes Technology Society.
PY - 2020/9
Y1 - 2020/9
N2 - Patients with diabetes may experience adverse outcomes related to their glycemic control when hospitalized. Continuous glucose monitoring systems, insulin-dosing software, enhancements to the electronic health record, and other medical technologies are now available to improve hospital care. Because of these developments, new approaches are needed to incorporate evolving treatments into routine care. With the goal of educating healthcare professionals on the most recent practices and research for managing diabetes in the hospital, Diabetes Technology Society hosted the Virtual Hospital Diabetes Meeting on April 24-25, 2020. Because of the coronavirus disease 2019 (COVID-19) pandemic, the meeting was restructured to be held virtually during the national lockdown to ensure the safety of the participants and allow them to remain at their posts treating COVID-19 patients. The meeting focused on (1) inpatient management and perioperative care, (2) diabetic ketoacidosis and hyperglycemic hyperosmolar state, (3) computer-guided insulin dosing, (4) Coronavirus Disease 2019 and diabetes, (5) technology, (6) hypoglycemia, (7) data and cybersecurity, (8) special situations, (9) glucometrics and insulinometrics, and (10) quality and safety. This meeting report contains summaries of each of the ten sessions. A virtual poster session will be presented within two months of the meeting.
AB - Patients with diabetes may experience adverse outcomes related to their glycemic control when hospitalized. Continuous glucose monitoring systems, insulin-dosing software, enhancements to the electronic health record, and other medical technologies are now available to improve hospital care. Because of these developments, new approaches are needed to incorporate evolving treatments into routine care. With the goal of educating healthcare professionals on the most recent practices and research for managing diabetes in the hospital, Diabetes Technology Society hosted the Virtual Hospital Diabetes Meeting on April 24-25, 2020. Because of the coronavirus disease 2019 (COVID-19) pandemic, the meeting was restructured to be held virtually during the national lockdown to ensure the safety of the participants and allow them to remain at their posts treating COVID-19 patients. The meeting focused on (1) inpatient management and perioperative care, (2) diabetic ketoacidosis and hyperglycemic hyperosmolar state, (3) computer-guided insulin dosing, (4) Coronavirus Disease 2019 and diabetes, (5) technology, (6) hypoglycemia, (7) data and cybersecurity, (8) special situations, (9) glucometrics and insulinometrics, and (10) quality and safety. This meeting report contains summaries of each of the ten sessions. A virtual poster session will be presented within two months of the meeting.
KW - diabetes
KW - digital health
KW - glucose
KW - hospital
KW - insulin
UR - http://www.scopus.com/inward/record.url?scp=85089382230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089382230&partnerID=8YFLogxK
U2 - 10.1177/1932296820939626
DO - 10.1177/1932296820939626
M3 - Article
C2 - 32783456
AN - SCOPUS:85089382230
SN - 1932-2968
VL - 14
SP - 928
EP - 944
JO - Journal of Diabetes Science and Technology
JF - Journal of Diabetes Science and Technology
IS - 5
ER -